LAUREN TETER: Open Payments
NPI 1710236112 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 57 payments from 15 companies in 2025. Trend: 2023 $1,207 · 2024 $1,330 · 2025 $1,309
Food & beverage: $1,142Education: $168
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $283 |
| GENZYME CORPORATION | 5 | $169 |
| LEO Pharma Inc. | 6 | $138 |
| Regeneron Healthcare Solutions, Inc. | 3 | $132 |
| Organon LLC | 6 | $106 |
| ABBVIE INC. | 4 | $92 |
| Incyte Corporation | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $51 |
| Amgen Inc. | 2 | $48 |
Products named: DUPIXENT, TREMFYA, VTAMA, ADBRY, OPZELURA, SKYRIZI, Cabtreo, OTEZLA.
Industry payments across MD — which companies pay providers there.
